As of June 7, 2025, ABVC Biopharma Inc (ABVC) reports a EV/EBITDA of -18.27.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing ABVC Biopharma Inc's EV/EBITDA to Peers
To better understand ABVC Biopharma Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| ABVC Biopharma Inc (ABVC) | -18.27 |
| Rayont Inc (RAYT) | 4.44 |
| Ether Capital Corp (ETHC.NE) | 4.15 |
| InnerScope Hearing Technologies, Inc. (INND) | 0.00 |
| HAVN Life Sciences Inc (HAVN.CN) | -0.03 |
| TraqIQ Inc (TRIQ) | -0.04 |
Compared to its competitors, ABVC Biopharma Inc's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.